Leflunomide

Assemble a 3D molecule model of the immunosuppresant drug Leflunomide (Arava) out of Authentic Molymod Model Parts by Indigo

Leflunomide is immunosuppressant drug used in the treatment of various forms of arthritis both may have promise in the treatment of other maladies such as Crohn's, Lupus & prostate cancer. 

A molecular model of Leflunomide in the Molymod Hybrid Dome style uses the atoms & bonds in the parts list below. Our free 3D Molecular Model Builder shows other styles & allows for image rotation as an assembly guide.

Chemical data
Molecular Weight Chemical Formula
270.2105 C12H9F3N2O2

Leflunomide molecular model built with Molymod Atoms & Bonds

Hybrid Dome
62053
Open Sphere
62009
Orbit Basic
68845NV
Orbit Flexible
68827W 68847W
Parts Synonyms
Parts
P/NDescriptionQTY
60116EAtom, Molymod, light green (halogen), 1 hole, 17mm3
60150EAtom, Molymod, white (hydrogen), hemisphere, 19mm9
60200EAtom, Molymod, red (oxygen), 2 hole, 105 degrees2
60311EAtom, Molymod, blue (nitrogen), 3 hole, 120 degrees, 23mm1
60400EAtom, Molymod, black (carbon), 4 hole, 109.5 degrees, 23mm12
60401EAtom, Molymod, blue (nitrogen), 4 hole, 109.5 deg., 23mm1
61012EBond, Molymod, grey (single), 20mm14
61013EBond, Molymod, grey (double/triple), 35mm12
61015EBond, Molymod, opaque, 2mm (for spacefilling models)9
Synonyms
5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide , 5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide , 5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide , 75706-12-6 , 210165-51-8 , SPECTRUM1503927 , LS-86580 , C07905 , Leflunomide , AIDS009747 , Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- , NSC677411 , EU-0100649 , IDI1_000916 , KBio2_000802 , NCGC00015610-01 , KBioSS_000802 , NCGC00022625-05 , AP-501/42475599 , NCGC00022625-06 , 4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl , 5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide , L5025_SIGMA , Spectrum_000322 , NCGC00022625-07 , Spectrum5_000850 , CAS-75706-12-6 , SU 101 , 4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)- , 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide , 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide , Arava , HSDB 7289 , HWA 486 , Leflunomida [INN-Spanish] , Leflunomide [USAN:INN] , Leflunomidum [INN-Latin] , N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide , SU 101 (pharmaceutical) , alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide , Lopac0_000649 , Arava (TN) , NCGC00015610-02 , Leflunomide (JAN/USAN/INN) , KBio2_003370 , HWA-486 , RS-34821 , SU-101 , Prestwick2_000772 , AIDS-009747 , Prestwick1_000772 , NINDS_000916 , SPBio_002783 , LEFUNAMIDE , KBio2_005938 , KS-1076 , D00749 , BPBio1_000930 , Prestwick3_000772 , Prestwick0_000772 , BSPBio_000844 , KBio1_000916 , Prestwick_87 , ZINC00004840 , MLS000069648 , DivK1c_000916 , Lopac-L-5025 , SMR000058209 , CHEBI:6402